Mrózek K - Search Results

1

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.

Langer C, Radmacher MD, Ruppert AS, Whitman SP, Paschka P, Mrózek K, Baldus CD, Vukosavljevic T, Liu CG, Ross ME, Powell BL, de la Chapelle A, Kolitz JE, Larson RA, Marcucci G, Bloomfield CD; Cancer and Leukemia Group B (CALGB). Langer C, et al. Among authors: mrozek k. Blood. 2008 Jun 1;111(11):5371-9. doi: 10.1182/blood-2007-11-124958. Epub 2008 Mar 31. Blood. 2008. PMID: 18378853 Free PMC article. Clinical Trial.

2

High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.

Baer MR, Christiansen NP, Frankel SR, Brunetto VL, Mrózek K, Bloomfield CD, Herzig GP. Baer MR, et al. Among authors: mrozek k. Semin Oncol. 1993 Dec;20(6 Suppl 8):6-12. Semin Oncol. 1993. PMID: 7507264

3

Band 11q13 is nonrandomly rearranged in hibernomas.

Mrózek K, Karakousis CP, Bloomfield CD. Mrózek K, et al. Genes Chromosomes Cancer. 1994 Feb;9(2):145-7. doi: 10.1002/gcc.2870090212. Genes Chromosomes Cancer. 1994. PMID: 7513546 Review.

4

Cytogenetics of indolent lymphomas.

Mrózek K, Bloomfield CD. Mrózek K, et al. Semin Oncol. 1993 Oct;20(5 Suppl 5):47-57. Semin Oncol. 1993. PMID: 8211207 Review. No abstract available.

5

Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.

Caligiuri MA, Schichman SA, Strout MP, Mrózek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD. Caligiuri MA, et al. Among authors: mrozek k. Cancer Res. 1994 Jan 15;54(2):370-3. Cancer Res. 1994. PMID: 8275471

6

Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.

Mrózek K, Karakousis CP, Bloomfield CD. Mrózek K, et al. Cancer Res. 1993 Apr 1;53(7):1670-5. Cancer Res. 1993. PMID: 8453640

7

Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia.

Baer MR, Bernstein SH, Brunetto VL, Heinonen K, Mrózek K, Swann VL, Minderman H, Block AW, Pixley LA, Christiansen NP, Fay JW, Barcos M, Rustum Y, Herzig GP, Bloomfield CD. Baer MR, et al. Among authors: mrozek k. Blood. 1996 Feb 15;87(4):1484-94. Blood. 1996. PMID: 8608239 Free article.

8

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.

Caligiuri MA, Strout MP, Schichman SA, Mrózek K, Arthur DC, Herzig GP, Baer MR, Schiffer CA, Heinonen K, Knuutila S, Nousiainen T, Ruutu T, Block AW, Schulman P, Pedersen-Bjergaard J, Croce CM, Bloomfield CD. Caligiuri MA, et al. Among authors: mrozek k. Cancer Res. 1996 Mar 15;56(6):1418-25. Cancer Res. 1996. PMID: 8640834

9

Isochromosome 12p in two cases of acute myeloid leukaemia without evidence of germ cell tumour.

Heinonen K, Rao PN, Slack JL, Cruz J, Bloomfield CD, Mrózek K. Heinonen K, et al. Among authors: mrozek k. Br J Haematol. 1996 Jun;93(3):677-80. doi: 10.1046/j.1365-2141.1996.d01-1687.x. Br J Haematol. 1996. PMID: 8652392

10

Have cancer cytogeneticists been wrong in assigning chromosome 12 breakpoints in benign tumors?

Mrózek K, Bloomfield CD. Mrózek K, et al. Genes Chromosomes Cancer. 1996 Mar;15(3):195-6. doi: 10.1002/1098-2264(199603)15:3<195::aid-gcc2870150302>3.0.co;2-g. Genes Chromosomes Cancer. 1996. PMID: 8721687 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page